Combo Regimens Effective for Tx of Metastatic Renal Cell Cancer
Two large trials show benefits for pembrolizumab-axitinib and avelumab-axitinib versus sunitinib
Experimental Test May Quickly Diagnose Sepsis
Microelectrode device analyzes a patient's blood, provides results in as quickly as 2.5 minutes
New Kaiser Permanente Medical School Plans to Waive Tuition
School will waive all tuition for the full four years of school for its first five classes
USPSTF Says Screen Women With Higher Risk for BRCA Mutations
Those with positive results should be provided with genetic counseling, testing if indicated
Inappropriate Use of Fentanyl Preps Seen Despite Awareness
Claims data show many prescribed transmucosal immediate-release fentanyl were opioid-nontolerant
FDA Warns About ‘Miracle’ Young Blood Infusion Treatments
Expensive 'fountain of youth' therapies are unproven, potentially harmful
Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
Incremental cost-effectiveness ratio varies across clinical risk groups, sensitive to patient age
Darolutamide Slows Spread of Castration-Resistant Prostate Cancer
Significant survival benefit seen, adverse events similar between darolutamide and placebo
Risk Factors ID’d for Diffuse Large B-Cell Lymphoma Mortality
In older patients, risk factors include advanced age, DLBCL stage, Charlson Comorbidity Index
Artificial Intelligence Predicts Survival in Epithelial Ovarian Cancer
Radiomic Prognostic Vector IDs patients with median overall survival of less than two years
